Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Videos

    A Closer Look At AstraZeneca plc

    | Mark Stones

    VIDEO: Two Fools put AstraZeneca plc (LON:AZN) under the spotlight.

    Read more »

    Investing Articles

    Beginners Portfolio: GlaxoSmithKline plc vs AstraZeneca plc

    | Alan Oscroft

    Was GlaxoSmithKline (LON: GSK) the best pharma pick for us, or would we be better with AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Should You Buy AstraZeneca plc Or Vodafone Group plc On Takeover Talk?

    | Mark Stones

    AstraZeneca plc (LON:AZN) and Vodafone Group plc (LON: VOD) could be lucrative investments, but make sure you ignore the rumours.

    Read more »

    Investing Articles

    Is AstraZeneca plc A Super Growth Stock?

    | Peter Stephens

    Although in the midst of facing a vast patent cliff, could AstraZeneca plc (LON: AZN) still be viewed as a…

    Read more »

    Investing Articles

    How Did AstraZeneca plc End Up Thrashing Rival GlaxoSmithKline plc?

    | Harvey Jones

    AstraZeneca plc (LON: AZN) has handed out a real thrashing to pharmaceutical rival GlaxoSmithKline plc (LON: GSK) lately, but Harvey…

    Read more »

    Investing Articles

    There’s A 14% Slump Ahead For AstraZenenca plc

    | Alan Oscroft

    Recovery might be coming for AstraZeneca plc (LON: AZN), but it'll take a few more years.

    Read more »

    Company Comment

    AstraZeneca plc Rises On Cancer Treatment Prospects

    | Mark Stones

    No mention of a potential Pfizer bid in AstraZeneca plc's (LON: AZN) latest results.

    Read more »

    Investing Articles

    Is There Still Time To Buy AstraZeneca plc?

    | Rupert Hargreaves

    Can AstraZeneca plc (LON: AZN) move higher, or are the company's shares overvalued?

    Read more »

    Investing Articles

    Don’t Bank On An AstraZeneca plc Bid Windfall

    | Tony Reading

    AstraZeneca plc (LON:AZN) might be taken over but rival GlaxoSmithKline plc (LON:GSK) has just done a better deal.

    Read more »

    Investing Articles

    AstraZeneca Plc’s 2 Greatest Weaknesses

    | Kevin Godbold

    Two standout factors undermining an investment in AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    AstraZeneca Plc’s Greatest Strengths

    | Kevin Godbold

    Two standout factors supporting an investment in AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    GlaxoSmithKline plc Tops The Pharmaceuticals sector

    | Alan Oscroft

    GlaxoSmithKline plc (LON: GSK) just edges out AstraZenenca plc (LON: AZN).

    Read more »